ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK Gsk Plc

1,607.00
7.00 (0.44%)
Last Updated: 09:58:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  7.00 0.44% 1,607.00 1,606.50 1,607.50 1,616.00 1,604.50 1,608.00 410,339 09:58:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.44 66.24B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,600p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,820.00p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £66.24 billion. Gsk has a price to earnings ratio (PE ratio) of 13.44.

Gsk Share Discussion Threads

Showing 32276 to 32298 of 33300 messages
Chat Pages: Latest  1296  1295  1294  1293  1292  1291  1290  1289  1288  1287  1286  1285  Older
DateSubjectAuthorDiscuss
06/6/2023
12:10
There won't be any surges until Zantac is out of the way .
abdullla
06/6/2023
09:09
With a massive 82% stake, institutions possess the maximum volume of shares in GSK. When the recovery takes place, I expect a big surge in the share price.
tradermichael
03/6/2023
23:11
This paper brings up the Sargon case which is worth being familiar of
berny3
03/6/2023
08:03
The uncertainty will likely persist for a longer time because there is bound to be a lengthy 'appeal' process, whichever way it goes..... ;0(
tradermichael
02/6/2023
10:17
I got back in on Tuesday, after being out since just before the split. Sold at a significant loss today so I can get back to sleeping at night. The bit that kept me awake was when I read that some of these 'class actions' would end up in front of a jury if the judge clears them for trial. GSK versus The People just doesn't sound good.
When all this uncertainty blows over I believe the company will thrive, I just don't have the will, or time, to see it through. Good luck to all who sail in her

jonjoneil
02/6/2023
08:04
That would suggest management competence.
spoole5
01/6/2023
17:37
Could it be possible that GSK would have insurance to cover any financial liabilities from Zantac claims?
jonjoneil
01/6/2023
15:40
Agree, it's a big risk..
rikky72
01/6/2023
15:22
Question is - even if the scientific evidence shows no proven link between Zantac and some types of cancer, can you trust the American legal system to do the right thing?
Remember how they screwed BP a few years back. Justice it ain't

jonjoneil
01/6/2023
14:18
Zantac's final bad news round the corner,maybe it is the reason for the daiySP drop .
abdullla
31/5/2023
20:06
I can also think of a few that actually went bust too...but like you say, a good example of equality in failure :) Also in common is the type of background most CEOs have - but probably enough politics for one evening.
Anyway, like ITV (where I have a low average, just like here at the time of print) I think I am going to make a profit here...as long as I do, then that is as far as my thinking goes. The game is the game, as Omar in The Wire said. Cannot change it. Good luck trying if you want to :)

lovewinshatelosses
31/5/2023
19:45
maybe they are dumping the shares instead
jonjoneil
31/5/2023
19:16
The CEO has failed, All the frankly ridiculous clichés spouted from the CEO about unlocking value, "new GSK" "leadership" , careful capital allocation is pure spin. The share price is £13.48 from ca £16.60 in 2017 when the CEO was appointed, The dividend has been cut, the market doesn't believe in the pipeline, the CEO or the leadership team . Six years plus under this CEO is too much time already. Why are the big institutional investors looking to dump the CEO and leadership team?
fidepax1
31/5/2023
18:17
Just shows female CEOs are just as rubbish as male ones. Look at ITV, AV. VOD etc etc.So much for positive discrimination.
chachacha
31/5/2023
17:38
Looking at the massive difference in share price between GSK and AZN, I thought some of it would be due to the relative number of shares in issue. I was amazed to see the figures GSK - 2.02 billion (after the split) against AZN - 3.09 billion. Can someone correct me if I am wrong?
jonjoneil
31/5/2023
14:44
Wonder if Emma will get a bonus! What was the price when she took over?
spoole5
31/5/2023
13:27
How about: 'GSK - Abandon hope of long term gains...just trade the dog!' Or is that too jazzy? :)
lovewinshatelosses
31/5/2023
13:18
Yes its looks like the low 1300's are coming!
gswredland
31/5/2023
11:51
Just add the word hope to the end 😂
tuftymatt
31/5/2023
11:50
Anyone suggest a more appropriate title to this thread?

'Glaxosmithkline - The recovery' doesn't make any sense

jonjoneil
31/5/2023
08:02
This morning would suggest that it has further South to go... ?...
theoriginalwonderstuff
31/5/2023
08:02
Emma gone yet?
spoole5
31/5/2023
06:56
Good luck to you to LWHL (& others who hold stock here)...
theoriginalwonderstuff
Chat Pages: Latest  1296  1295  1294  1293  1292  1291  1290  1289  1288  1287  1286  1285  Older

Your Recent History

Delayed Upgrade Clock